Purple Biotech Ltd.

Contributing Author

Recent Articles by Purple Biotech Ltd.

Jun-23	Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress PPBT GlobeNewswire
Jun-17	Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer PPBT GlobeNewswire
Jun-04	Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform PPBT GlobeNewswire
May-21	Purple Biotech Reports First Quarter 2025 Financial Results PPBT GlobeNewswire
May-12	Purple Biotech Appoints Shai Lankry as Chief Financial Officer PPBT GlobeNewswire